Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

MLSS opened at $0.95 on Friday. Milestone Scientific has a fifty-two week low of $0.58 and a fifty-two week high of $1.39. The firm has a market capitalization of $74.46 million, a PE ratio of -13.57 and a beta of 0.93. The company’s 50-day moving average is $0.96 and its 200 day moving average is $0.97.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of MLSS. XTX Topco Ltd lifted its stake in Milestone Scientific by 99.2% during the 1st quarter. XTX Topco Ltd now owns 34,135 shares of the company’s stock valued at $32,000 after acquiring an additional 17,002 shares in the last quarter. Carnegie Investment Counsel raised its holdings in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares in the last quarter. Brookwood Investment Group LLC purchased a new position in Milestone Scientific during the first quarter worth about $46,000. Finally, Renaissance Technologies LLC grew its position in Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares in the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.